Filing Flows › Agape ATP (ATPC) › Product Health Therapies revenue
Agape ATP (ATPC) Product Health Therapies revenue by quarter
Agape ATP's Product Health Therapies revenue was $16K in Q2 2026 (second quarter 2026), -93% from Q1 2026. Over the last 6 quarters it ranged from $16K (Q2 2026) to $261K (Q4 2025).
| Quarter | Product Health Therapies revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $16K | -93% | -93% |
| Q1 2026 | $214K | -18% | +2% |
| Q4 2025 | $261K | +17% | — |
| Q3 2025 | $223K | +2% | — |
| Q2 2025 | $219K | +4% | — |
| Q1 2025 | $210K | — | — |
Q2 2026 at a glance
Agape ATP, Q2 2026: revenue $109K (-77% year over year), operating margin -505.0%, net earnings $153K, operating cash flow −$110K. The chart follows the revenue to costs, profit and cash.
Questions
What is Agape ATP's Product Health Therapies revenue?
Agape ATP's Product Health Therapies revenue was $16K in Q2 2026 (second quarter 2026), -93% from Q1 2026.
How has Agape ATP's Product Health Therapies revenue changed?
Over the last 6 quarters it ranged from $16K (Q2 2026) to $261K (Q4 2025).